Download pdf
Breast Cancer in Young Women: Epidemiology, Risk Factors, and Screening Challenges
- 1 Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY, United States
- 2 School of Medicine, Xiamen University, Xiang'an South Road, Xiang'an District, Xiamen, Fujian, China
* Author to whom correspondence should be addressed.
Abstract
Breast cancer is the most commonly diagnosed cancer among women worldwide, with an estimated 2.3 million new cases annually. In the United States, it accounts for 15.5% of all new cancer cases in 2024, with over 42,000 deaths reported annually. Despite advancements in detection and treatment, mortality remains a concern. This paper explores breast cancer’s biological and clinical characteristics, risk factors, and screening strategies, with a particular focus on young women. The disease originates from abnormal cell growth in breast tissue and is classified into various subtypes based on molecular markers. Key risk factors include age, genetic predisposition (e.g., BRCA mutations), and lifestyle influences such as obesity and alcohol consumption. The disease often manifests in a more aggressive form with less favorable outcomes in younger women.Early detection through mammography significantly reduces mortality, but debates persist over the optimal screening age due to concerns about false positives and overdiagnosis. This study examines existing screening guidelines, the economic burden of screening, and barriers to access for young women. This study examines approaches to boost early detection and close the gaps in breast cancer survival rates. It also highlights the critical need for addressing inequalities by increasing diversity in clinical trials and providing equal access to high-quality care and screening.
Keywords
breast cancer, young women, screening, risk factors, disparities
[1]. World Health Organization. Breast Cancer. 13 March 2024. https://www.who.int/news-room/factsheets/detail/breastcancer#:~:text=Scope%20of%20the%20problem, women%20will%20die%20from%20it.
[2]. National Cancer Institute: Surveillance, Epidemiology, and End Results Program. Cancer Stat Facts: Female Breast Cancer. https://seer.cancer.gov/statfacts/html/breast.html#:~:text=Estimated%20New%20Cases%20in%202024, 91.2%25%202014–2020.
[3]. Tracey A. Martin et al. Cancer Invasion and Metastasis: Molecular and Cellular Perspective. 2013. Madame Curie Bioscience Database [Internet]. https://www.ncbi.nlm.nih.gov/books/NBK164700/?utm.
[4]. Umberto Veronesi et al. Breast Cancer. May 2025. The Lancet. https://www.sciencedirect.com/science/article/pii/S0140673605665464.
[5]. Adrienne G. Waks; Eric P. Winer. Breast Cancer Treatment A Review. JAMA, January 22, 2019. https://jamanetwork.com/journals/jama/fullarticle/2721183.
[6]. Gopal et al. Breast Cancer. February 25, 2024. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK482286/.
[7]. Jennifer L Gnerlich et al. Elevated Breast Cancer Mortality in Young Women (<40 Years) Compared with Older Women Is Attributed to Poorer Survival in Early Stage Disease. Jan 20, 2012. J Am Coll Surg. https://pmc.ncbi.nlm.nih.gov/articles/PMC3262236/#:~:text=INTRODUCTION.%20Although%20breast%20cancer%20risk%20increases%20with, younger%20than%2040%20years%20of%20age%20(1).
[8]. Kevin C. Oeffinger et al. Breast Cancer Screening for Women at Average Risk. October 20, 2015. JAMA Network. https://jamanetwork.com/journals/jama/fullarticle/2463262.
[9]. Weigang Wang et al. Clinical features and prognostic factors of breast cancer in young women: a retrospective single-center study. Mar 2023 Mar. Arch Gynecol Obstet. https://pubmed.ncbi.nlm.nih.gov/35835921/.
[10]. Carey K Anders et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. July 10, 2008. J Clin Oncol. https://pubmed.ncbi.nlm.nih.gov/18612148/.
[11]. Lynn Chollet-Hinton et al. Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study. August 04, 2016. https://breast-cancer-research.biomedcentral.com/articles/10.1186/s13058-016-0736-y.
[12]. Andrew J Rettenmaier, Zijun Wang. Regional variations in medical spending and utilization: a longitudinal analysis of US Medicare population. Feb 2012. https://pubmed.ncbi.nlm.nih.gov/22223553/.
[13]. Natalia Kunst et al. Understanding regional variation in the cost of breast cancer screening among privately insured women in the United States. May 1, 2021. Med Care. https://pmc.ncbi.nlm.nih.gov/articles/PMC8611614/#:~:text=The%20cost%20of%20breast%20cancer%20screening%20per%20screened, costs%20of%20screening-%20and%20diagnostics-related%20procedures%20%28Table%202%29.
[14]. Derek L Nguyen et al. Addressing Disparities Related to Access of Multimodality Breast Imaging Services Before and During the COVID-19 Pandemic. March 25, 2022. Acad Radiol. https://pmc.ncbi.nlm.nih.gov/articles/PMC8947962/#:~:text=This%20benefit%20is%20only%20applicable, improved%20screening%20technology%20(36).
[15]. U.S. Preventive Services TASK FORCE. April 30, 2024. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-screening.
[16]. American Cancer Society. Recommendations for the Early Detection of Breast Cancer. December 19, 2023. https://www.cancer.org/cancer/types/breast-cancer/screening-tests-and-early-detection/american-cancer-society-recommendations-for-the-early-detection-of-breast-cancer.html#:~:text=*%20Having%20a%20personal%20history%20of%20breast, dense%20breasts%20as%20seen%20on%20a%20mammogram.
[17]. Memorial Sloan Kettering Cancer Center. Screening for breast cancer. https://www.mskcc.org/cancer-conditions/breast-cancer#screening.
[18]. Jen Uscher, Tyler Santora. When to Get a Mammogram. January 14, 2025. Breastcancer.org. https://www.breastcancer.org/screening-testing/mammograms/recommendations.
Cite this article
Chen,R.;Xu,S. (2025). Breast Cancer in Young Women: Epidemiology, Risk Factors, and Screening Challenges. Theoretical and Natural Science,96,27-34.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
About volume
Volume title: Proceedings of the 5th International Conference on Biological Engineering and Medical Science
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).